Encompass Health Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Encompass Health Corporation
- Former names
- Healthsouth Corp Healthsouth Rehabilitation Corp
- Ownership
- Public
- Status
- Active
- SIC code
- 8060 — Services-Hospitals
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Birmingham
- Headquarters state / province
- Alabama
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- EHC
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000785161
- EIN
- 63-0860407
Board of directors
-
Cain A. Hayes · DirectorSince 2026
-
Christopher R. Reidy · DirectorSince 2023
-
Donald L. Correll · DirectorSince 2023
-
Edward M. Christie III · DirectorSince 2023
-
Greg D. Carmichael · DirectorSince 2023
-
Joan E. Herman · DirectorSince 2023
-
John Chidsey · DirectorSince 2023
-
Kevin J. O'Connor · DirectorSince 2023
-
Leslye G. Katz · DirectorSince 2023
-
Mark J. Tarr · Director · President & CEOSince 2023
-
Nancy M. Schlichting · DirectorSince 2023
-
Patricia Anne Maryland · DirectorSince 2023
-
Terrance Williams · DirectorSince 2023
Chief executives
Mark J. Tarr
· President & CEO
Dates unknown
Director election results
Annual meeting of May 7, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.0%
-
97.4%
-
97.8%
-
97.9%
-
97.9%
-
98.2%
-
98.3%
-
98.9%
-
99.2%
-
99.4%
Board connections
8 of this board's directors also sit on 10 other boards.
- via Nancy M. Schlichting
- via Cain A. Hayes
- via Christopher R. Reidy
- via Greg D. Carmichael
- via John Chidsey
- via Joan E. Herman
- via Donald L. Correll
- via John Chidsey
- via Patricia Anne Maryland
- via Patricia Anne Maryland
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $47,785,597
- 18 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Darby John Patrick Officer (EVP, Gen Counsel & Secretary) | Option exercise | +4,858 | $35.06 | $170,321 |
| Aug 31, 2026 | Price Andrew L Officer (Chief Accounting Officer) | Open-market sale | −5,211 | $120.93 | $630,166 |
| Aug 31, 2026 | Darby John Patrick Officer (EVP, Gen Counsel & Secretary) | Open-market sale | −4,858 | $121.09 | $588,255 |
| Aug 10, 2026 | Douglas E. Coltharp Officer (EVP & Chief Financial Officer) | Open-market sale | −18,869 | $125.38 | $2,365,795 |
| Aug 10, 2026 | Darby John Patrick Officer (EVP, Gen Counsel & Secretary) | Open-market sale | −8,906 | $125.95 | $1,121,711 |
| Aug 10, 2026 | Mark J. Tarr Director, Officer (President & CEO) | Open-market sale | −171,569 | $125.46 | $21,525,047 |
| Aug 10, 2026 | Mark J. Tarr Director, Officer (President & CEO) | Open-market sale | −1,579 | $126.06 | $199,049 |
| Jul 16, 2026 | Edward M. Christie III Director | Grant or award | +248 | $112.43 | $27,883 |
| Jul 16, 2026 | Christopher R. Reidy Director | Grant or award | +319 | $112.40 | $35,856 |
| Jul 15, 2026 | Greg D. Carmichael Director | Grant or award | +29 | — | — |
| Jul 15, 2026 | Edward M. Christie III Director | Grant or award | +11 | — | — |
| Jul 15, 2026 | Cain A. Hayes Director | Grant or award | +4 | — | — |
| Jul 15, 2026 | Joan E. Herman Director | Grant or award | +85 | — | — |
| Jul 15, 2026 | Leslye G. Katz Director | Grant or award | +85 | — | — |
| Jul 15, 2026 | Kevin J. O'Connor Director | Grant or award | +19 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.